Chief Technology Officer @ (July 2019 - December 2024)
VP, Manufacturing @ (September 2018 - January 2021)
VP, Biologics Manufacturing @ (November 2013 - February 2017)
Head of Manufacturing Department @ (August 2010 - October 2013)
Bioprocessing Section Head @ (January 2004 - January 2010)
Biologics Product Discovery and Development @ (January 2001 - January 2010)
Postdoctoral Scientist @ (July 1998 - January 2001)
PhD @ Glaxo BRI (January 1995 - June 1998)
Greg Elson Education
The University of Manchester 1990-1994
Millfield 1985-1990
Greg Elson Skills
Analytical Methods
ELISA
Analytical Methods Development
GMP
Sales
Antibodies
Accountability
Clinical Research
Assay Development
Biotechnology
Cell
Immunology
Team Management
Inflammation
Validation
Protein Engineering
Strategic Planning
Toll Like Receptors
Drug Discovery
Drug Development
Process Development
Clinical Development
Monoclonal Antibodies
Bispecific Antibodies
Biologics
Process Development And Validation
CMC
Management
Pharmaceutical Industry
Technology Transfer
Cytokines
Biomarker Discovery
Biopharmaceuticals
Downstream Processing
Regulatory Affairs
Upstream Processing
Protein Purification
Protein Characterization
Greg Elson Summary
Greg Elson, based in Geneva, GE, CH, is currently a Prevail BioPharma Solutions at Independent Consultant. Greg Elson brings experience from previous roles at Alentis Therapeutics, Amal Therapeutics, Glenmark Pharmaceuticals and NovImmune. Greg Elson holds a 1990 - 1994 The University of Manchester. With a robust skill set that includes Analytical Methods, ELISA, Analytical Methods Development, GMP, Sales and more. Greg Elson has 1 emails on RocketReach.
Looking for a different Greg Elson?
Find contact details for 700 million professionals.